KOD
Kodiak Sciences Inc
Halal Rating :
Last Price
$7.17
Last updated:
Market Cap
-
7D Change
-8.26%
1 Year Change
119.11%
Company Overview
Industries
Exchange
Next Earnings Date
Kodiak Sciences Inc. is a biopharmaceutical company focused on researching and developing novel therapies for the treatment of retinal diseases. The company's primary focus is on developing treatments for age-related macular degeneration, diabetic macular edema, and other serious retinal diseases.
The company is currently in the research and development phase and has not yet commercialized any products. Their lead product candidate is tarcocimab tedromer, which is being developed for various retinal vascular diseases.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|
Company Impact
Help us evaluate Kodiak Sciences Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.